RFK Jr. set to ban common food dyes from food supply including colorings for M&Ms, Lucky Charms and Gatorade
The Trump administration says the move could mark a 'major step forward' in the drive to 'Make America Healthy Again.' The ban would impact products such as breakfast cereals, candy and snacks. They dyes been tied to neurological problems in some children.
'We've shown now that this directly affects academic performance, violence in the schools, and mental health, as well as physical health,' Kennedy said at a cabinet meeting earlier this month.
It is unclear when the changes could be implemented, but Kennedy is slated to give more details later Tuesday.
The secretary is anticipated to announce the approval of additional natural dyes, a person familiar with the plans told ABC News.
Here are the dyes that could be up on the chopping block and what they're commonly found in:
Red No. 40 – Pepsi Blue, Starburst and medication NyQuil.
Citrus Red No. 2 – Used to color the skin of some oranges
Yellow No. 6 – Airheads and cosmetic products including Bobbi Brown and MAC lipstick.
Yellow No. 5 – Mountain Dew and Doritos
Blue No. 1 – Blue Takis chips and MAC eyeshadow
Blue No. 2 – Oxycodone and a common bakery McCormick food dye.
Green No. 3 – Advil Liquid-gels
Recent research shows synthetic food colors found in U.S. foods are linked to neurobehavioral problems in children and that the dyes may cause or exacerbate symptoms, particularly hyperactivity. In addition, children may vary widely in their sensitivity to the dyes.
'It is clear that some children are likely to be more adversely affected by food dyes than others,' the California's Office of Environmental Health Hazard Assessment reported in 2021.
Nevertheless, there is no clear evidence of a direct relationship between food dyes, academic performance, violence or other mental and physical conditions, scientists say.
Scientific evidence shows that 'most children have no adverse effects when consuming foods containing color additives,' according to the FDA.
The FDA banned the dye known as Red 3 from the nation's food supply in January. It said the dye, also known as erythrosine, caused cancer in lab rats. A federal law requires the administration to ban any additive found to cause cancer in animals. However, officials stressed that the way Red 3 leads to cancer in rats doesn't happen in people.
Dr. Peter Lurie, a former FDA official, told the BBC that the only purpose of the artificial food dyes is to "make food companies money.'
"Food dyes help make ultra-processed foods more attractive, especially to children, often by masking the absence of a colorful ingredient, like fruit," he said. "We don't need synthetic dyes in the food supply, and no one will be harmed by their absence."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
Discrete medical device linked to lower risk of dementia
Hearing aids could slash the risk of dementia by almost two thirds, new findings suggest. Hearing loss has been strongly linked to neurogenerative diseases such as Alzheimer's and other forms of dementia. While the exact mechanisms are unclear, one of the theories is that when the brain has to work harder to process a degraded auditory signal, it diverts resources from other cognitive functions, potentially accelerating cognitive decline. With this in mind, a team of researchers in the US looked at data from 2,953 participants over a 20 year period to analyze how hearing aid use could help ward off signs of dementia. From their analysis, they found participants with hearing loss who wore hearing aids had a 61 percent lower risk of dementia compared to those who did not wear the devices. However, they highlighted that only 17 percent of individuals with moderate to severe hearing loss use hearing aids. The researchers say the findings 'underscore the importance of early intervention for hearing loss to reduce risk of incident dementia'. The study's finding show similar results to previous research. A 2023 study of nearly 1,000 adults by Johns Hopkins University School of Medicine compared the rate of cognitive decline over a three-year period between people who did and didn't receive hearing aids. Researchers found those who received hearing aids had a 48 percent reduction in the rate of cognitive decline compared with people who didn't get the devices. In response, Professor Frank Lin, of Johns Hopkins University School of Medicine and Bloomberg School of Public Health, said: 'These results provide compelling evidence that treating hearing loss is a powerful tool to protect cognitive function in later life, and possibly, over the long term, delay a dementia diagnosis. 'But any cognitive benefits of treating age-related hearing loss are likely to vary depending on an individual's risk of cognitive decline.' Along with hearing loss putting an increased workload on the brain, Professor Lin believes that it can also make people feel more isolated and less socially engaged, which can contribute to dementia. He explained: 'When you have hearing loss, you may not be as socially engaged. 'You may become more lonely or withdrawn. One thing we know about risk of dementia and cognitive decline is that if people don't remain engaged with cognitively stimulating activities, it is not good for the brain.' Hearing loss has been strongly linked to neurogenerative diseases such as Alzheimer's, but it has so far been unclear whether it is a symptom or one of the causes behind the illness. Age-related hearing loss is extremely common, with an estimated one in three people over 60 in the US having some degree of hearing loss, with women at a slightly higher risk than men. However, only around a third of this population use hearing aids. In the US, over 7 million individuals aged 65 and older are living with Alzheimer's disease with this number projected to nearly double to 13 million by 2050. It is thought to be caused by a build-up of amyloid and tau in the brain, which clump together and from plaques and tangles that make it harder for the brain to work properly. Eventually, the brain struggles to cope with this damage and dementia symptoms develop. Memory problems, thinking and reasoning difficulties and language problems are common early symptoms of the condition, which then worsen over time. The condition is more prevalent among females, with around two-thirds of cases occurring in women. The increased risk among women is attributed to a combination of factors, including women's longer life expectancy, hormonal changes associated with menopause, genetic predispositions, and lifestyle influences. Other risks for dementia include high blood pressure, lack of physical activity, smoking, alcohol use and uncontrolled diabetes. Over-the-counter (OTC) hearing aids can be purchased directly from retail stores or online without a prescription or professional fitting by an audiologist. However, audiologists can also provide prescription-strength hearing aids, which may be necessary for more severe hearing loss or for those who prefer a customized fitting. Despite them being readily available, many people still don't seek help or wear hearing aids because of the perceived stigma around them. However, with technological advancements and a growing preference for sleek, discreet designs, hearing aids are becoming increasingly popular. The hearing aids market is expected to reach $45.68 billion by 2031, an increase from $28.75 billion in 2024, which experts say is largely due to an aging population. Previous research has suggested hearing loss can contribute to a faster rate of brain wasting as well as prompt social isolation – another known risk factor of mental decline. Scientists also believe it may also make the brain work harder to the detriment of other mental functions like thinking and memory.
Reuters
4 hours ago
- Reuters
Vaccine panel fired by Kennedy had lowest rate of financial conflicts since 2000, study shows
Aug 18 (Reuters) - Conflicts of interest on the U.S. Centers for Disease Control and Prevention's vaccine advisory committee were at historic lows around the time when Health Secretary Robert F. Kennedy Jr. fired all 17 members in June, new data published in a medical journal on Monday showed. Kennedy had said, based on findings from a 2007 report, that the Advisory Committee on Immunization Practices (ACIP) was rife with conflicts. The new study published in JAMA, opens new tab found that between 2000 and 2024, ACIP's annual reported conflict of interest rate declined from 42.8% to 5%. ACIP advises on which groups of people should take each vaccine approved by the U.S. Food and Drug Administration, and when they should be administered. Conflict of interest rates on the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), which advises the agency on whether to approve vaccines, have remained below 4% since 2010, including 10 years when it was 0%, the researchers also found. The most frequently reported conflict of interest was funding for research, which is generally considered less concerning than financial ties associated with personal income, the researchers said. The prevalence of conflicts related to personal income – such as from consulting, royalties, or stock ownership – had been below 1% for both committees since 2016. 'In the past, there have been high levels of reported conflicts on influential vaccine committees, but there has been substantial progress since the early 2000s,' study leader Genevieve Kanter of the Schaeffer Center at the University of Southern California said in a statement. 'Secretary Kennedy is right that conflict of interest is an important issue, but he is wrong that it is present at substantial levels on (U.S. Department of Health and Human Services) vaccine advisory committees,' co-author Peter Lurie, president of the Center for Science in the Public Interest and former FDA associate commissioner, said in a statement. Responding to the study, Department of Health and Human Services press secretary Emily Hilliard said, "Secretary Kennedy is committed to eliminating both real and perceived conflicts to strengthen confidence in public health decisions." Earlier this year, the agency launched its ACIP Conflicts of Interest Disclosures tool, opens new tab, she noted.
The Independent
4 hours ago
- The Independent
Could this be the alternative to LASIK surgery?
LASIK eye surgery has been performed successfully in the U.S. since the late 90s, helping nearly 40 million patients to improve their vision through a procedure that cuts into the eye using lasers. Some 600,000 of the Food and Drug Administration-approved surgeries are carried out on American adults each year. Now, researchers say they have come up with an alternative method that wouldn't need invasive incisions and could be cheaper. It uses a process called electromechanical reshaping, which helps to reshape the cornea using electrical current. The cornea is a dome-shaped, clear structure at the front of the eye that helps us to process images. Irregularly shaped corneas are the cause of nearsighted and farsighted vision and astigmatism, and LASIK fixes that by burning away tissue to reshape it. 'The whole effect was discovered by accident,' Brian Wong, a professor and surgeon at the University of California, Irvine, explained in a statement. 'I was looking at living tissues as moldable materials and discovered this whole process of chemical modification.' While the work is in its early stages, it could offer an alternative to LASIK. Although the surgery has been safely performed for nearly 30 years with rare complications, it has some limitations and risks. The surgeons say that cutting the cornea compromises the structural integrity of the eye. This procedure has yet to be performed in humans, but researchers previously used electromechanical reshaping to alter scars and skin in pigs and reshape cartilage-rich rabbit ears. Working with rabbit eyeballs, they constructed platinum 'contact lenses' that served as a template for the corrected shape of the cornea, placing them over a rabbit eyeball in a saline solution meant to mimic natural tears. After about a minute following a small electric charge to the lens, the cornea's curvature conformed to the shape of the lens. That happened in the same amount of time as LASIK, with fewer steps, no incisions, and less expensive equipment. Then, they repeated the step on 12 other rabbit eyeballs. Of those dozen, 10 were treated as if they had nearsighted vision, and the researchers found success. In others, they saw that their technique might be able to reverse some chemical-caused cloudiness to the cornea, which is currently only treatable through a complete transplant of the cornea. In the future, the researchers are planning tests on living rabbits, and looking at far-sightedness and astigmatism. Uncertainties in the team's scientific funding have put those plans on hold, but Michael Hill, a professor of chemistry at Occidental College, will present their findings this week at the fall meeting of the American Chemical Society. 'There's a long road between what we've done and the clinic. But, if we get there, this technique is widely applicable, vastly cheaper and potentially even reversible,' said Hill.
